These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 8485833
1. Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms. Schultheiss HP. Circulation; 1993 May; 87(5 Suppl):IV43-8. PubMed ID: 8485833 [Abstract] [Full Text] [Related]
2. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Schulze K, Becker BF, Schultheiss HP. Circ Res; 1989 Feb; 64(2):179-92. PubMed ID: 2536302 [Abstract] [Full Text] [Related]
3. Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure? Schultheiss HP, Schulze K, Schauer R, Witzenbichler B, Strauer BE. Circ Res; 1995 Jan; 76(1):64-72. PubMed ID: 8001279 [Abstract] [Full Text] [Related]
5. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Schulze K, Witzenbichler B, Christmann C, Schultheiss HP. Cardiovasc Res; 1999 Oct; 44(1):91-100. PubMed ID: 10615393 [Abstract] [Full Text] [Related]
6. The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. Schulze K, Schultheiss HP. Eur Heart J; 1995 Dec; 16 Suppl O():64-7. PubMed ID: 8682105 [Abstract] [Full Text] [Related]
7. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Schultheiss HP. Basic Res Cardiol; 1992 Dec; 87 Suppl 1():311-20. PubMed ID: 1497575 [Abstract] [Full Text] [Related]
8. Cardiac cytotoxic mechanism mediated by antibodies against myocardial mitochondrial ADP/ATP carrier in patients with dilated cardiomyopathy. Liao Y, Tu Y, Chen L, Dai S, Peng Y, Li S, Zhang J. Chin Med J (Engl); 1996 Mar; 109(3):193-6. PubMed ID: 8758307 [Abstract] [Full Text] [Related]
12. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Walther T, Tschöpe C, Sterner-Kock A, Westermann D, Heringer-Walther S, Riad A, Nikolic A, Wang Y, Ebermann L, Siems WE, Bader M, Shakibaei M, Schultheiss HP, Dörner A. Circulation; 2007 Jan 23; 115(3):333-44. PubMed ID: 17210842 [Abstract] [Full Text] [Related]
13. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts. Tatsumi T, Akashi K, Keira N, Matoba S, Mano A, Shiraishi J, Yamanaka S, Kobara M, Hibino N, Hosokawa S, Asayama J, Fushiki S, Fliss H, Nakagawa M, Matsubara H. J Mol Cell Cardiol; 2004 Sep 23; 37(3):775-84. PubMed ID: 15350850 [Abstract] [Full Text] [Related]
14. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy. Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Dalla Volta S. G Ital Cardiol; 1997 Feb 23; 27(2):106-12. PubMed ID: 9199945 [Abstract] [Full Text] [Related]
20. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy. Wang Z, Liao Y, Dong J, Li S, Wang J, Fu ML. Chin Med J (Engl); 2003 Apr 23; 116(4):499-502. PubMed ID: 12875710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]